Innovative Minds: insights from the next generation of scientist-entrepreneurs

March 18, 2025

Photograhpy by Monika Vaskorova

Explore the journeys of UvA Researchers Tijmen Bakker, Olivier Lugier, and Ewelina Weglarz-Tomczak as they transformed their research into impactful startups. From developing solar cells and nanoparticles to creating enzyme-based treatments against Alzheimer’s, these scientists share their experiences of overcoming obstacles, securing funding, and utilizing university support in the context of becoming fellow’s in the Faculty of Impact.

Tijmen Bakker (34), founder Lightcore

“I only just made it into the first intake of the Faculty of Impact, with the lowest score of the ten participants. I had written a proposal to use transparent, coloured solar cells, which I had worked on in the lab during my PhD, to provide lighting for greenhouse farming.” […] “There is an idea and a prototype, but now comes the bridging phase: the valley of death. This is the most difficult phase for a start-up to find financing if there is no product yet, especially in the Netherlands. Only 22 percent of Dutch start-ups eventually grow into a scale-up.”

Olivier Lugier (30) founder Nano Hybrid

“I never thought I would be able to start up a company myself. In chemistry, and more generally in deep tech you need a lab with equipment, so you have to invest a lot at the beginning. It’s really a chance to have the support of the university’s ecosystem in the first year.”

“[…] I’m not too worried about the business climate in the Netherlands: that kind of thing can change again in a few years’ time, so even if I monitor it, I can’t plan for it, especially at that stage of the business.”

Ewelina Weglarz-Tomczak, founder NatInLab

“[…] I have gained more insight into entrepreneurship, business development and the steps needed to bring an innovative idea to market. The programme [Faculty of Impact. red.] helped me refine my vision, strengthen my strategic thinking and develop the skills needed to tackle challenges in the biotech industry. I also learned about the importance of networking, collaborating and effectively communicating my scientific expertise to various stakeholders, from investors to potential partners.”

Curious to read the interviews with Tijmen, Olivier and Ewelina in full? Please turn to Folia.

More news

Optics11’s new partnership for breakthrough underwater surveillance by Royal Netherlands Navy

VU spin-off Optics11, partners with Thales to equip Dutch submarines with advanced sonar technology to enhance underwater surveillance capabilities. The ability for the Royal Navy to detect threats in deep waters ensures that potential dangers are identified early. Ultimately, the advancements contribute to stronger national security, safeguarding our interests and maintaining stability.  Thales delivers cutting-edge Sonar […]

News

Madglove Amsterdam secures Rabobank Innovation Loan to drive further growth 

Madglove Amsterdam B.V., originally founded at the Vrije Universiteit’s Demonstrator Lab, is proud to announce that it has secured the full Rabobank Innovation Loan. This funding enables the company to continue its mission of viewing disabilities as a form of diversity and providing innovative solutions for individuals with physical limitations.  Jeremiah Oluwatobi Makinde, COO of […]

News

RehabAI@Home: public-private innovation for advancing rehabilitation 

With RehabAI@Home, there is a unique public-private partnership between VU Amsterdam, Amsterdam UMC, Hogeschool van Amsterdam, and ROM InWest. The goal is to elevate innovation in rehabilitation care by combining science, artificial intelligence (AI), and entrepreneurship, making home rehabilitation more accessible and effective.   Why RehabAI@Home?   Healthcare faces significant challenges: The number of people […]

News
All news